• Physician-scientists present updated efficacy data on CAR T-cell gene immunotherapy

    5 days ago - By News Medical

    Physician-scientists from Children's Hospital of Philadelphia presented updated efficacy and safety data on Kymriah-the first-ever U.S. Food and Drug Administration approved personalized CAR T-cell gene immunotherapy for aggressive blood cancers at the 60th American Society of Hematology annual meeting, as well as first-of-its-kind research on overcoming CAR T-cell resistance.
    Read more ...